![](/img/cover-not-exists.png)
63 POSTER Improved antitumor activity by combining ZD644 (ZACTIMA) with rediotherapy and irinotecan in the LoVo human colorectal cancer xenograft model
P. Wachsberger, R. Burd, T. Strickler, K. Kulp, A. Ryan, A. DickerVolume:
4
Year:
2006
Language:
english
DOI:
10.1016/s1359-6349(06)70069-6
File:
PDF, 61 KB
english, 2006